Triazolpyridinforbindelser som PIM-kinasehæmmere

Compounds of Formula (I), in which A, B, R1, R1a, R2, R3, R4, R5, R6, and R7 have the meanings given in the specification, are receptor tyrosine inhibitors useful in the treatment of immune cell-associated diseases and disorders, such as inflammatory and autoimmune diseases.

Saved in:
Bibliographic Details
Main Authors RAST, BRYSON, DELISLE, ROBERT KIRK, MARMSATER, FREDRIK, P, DAVIS, T. GREGG, TOPALOV, GEORGE T, JACKSON, LEILA, J, WRIGHT, A. DALE, CELESTE, LAURA L, LYSSIKATOS, JOSEPH, P, MUNSON, MARK, C, ZHAO, QIAN, KALLAN, NICHOLAS C, PHENEGER, JED, HICKEN, ERIK, JAMES, GROSS, STEFAN, D, ROBINSON, JOHN, E, GRESCHUK, JULIE MARIE, ALLEN, SHELLEY, SCHLACHTER, STEPHEN T
Format Patent
LanguageDanish
Published 18.11.2013
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:Compounds of Formula (I), in which A, B, R1, R1a, R2, R3, R4, R5, R6, and R7 have the meanings given in the specification, are receptor tyrosine inhibitors useful in the treatment of immune cell-associated diseases and disorders, such as inflammatory and autoimmune diseases.
Bibliography:Application Number: DK20090791625T